Fitusiran Is a Drug to Watch in the Hematology Space in 2025
Pharmacy Times
FEBRUARY 1, 2025
Fitusiran is part of a generation of novel RNA interference therapies and is designed for subcutaneous administration for the prophylactic treatment of hemophilia A or B.
Let's personalize your content